The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation
Lancet
.
2023 Oct 28;402(10412):1507-1510.
doi: 10.1016/S0140-6736(23)01775-0.
Epub 2023 Sep 6.
Authors
Victor Dzau
1
,
Soumya Swaminathan
2
,
Charlotte Baker
3
,
Rick A Bright
4
,
Jose Castillo
5
,
Tan Chorh Chuan
6
,
Ruxandra Draghia-Akli
7
,
Ranna Eardley-Patel
8
,
George F Gao
9
,
Ken Ishii
10
,
Yenew Kebede Tebeje
11
,
Teresa Lambe
12
,
Shingai Machingaidze
11
,
John-Arne Røttingen
13
,
Umesh Shaligram
14
,
Mariângela Simão
15
,
Renu Swarup
16
,
Jean-Francois Toussaint
17
,
Niteen S Wairagkar
11
Affiliations
1
US National Academy of Medicine, Washington, DC, USA.
2
M S Swaminathan Research Foundation, Chennai, India.
3
International Pandemic Preparedness Secretariat, London NW1 2BE, UK. Electronic address:
[email protected]
.
4
Foundation for Innovative New Diagnostics, Geneva, Switzerland.
5
Univercells, Nivelles, Belgium.
6
Singapore Ministry of Health, Singapore.
7
Johnson & Johnson, New Brunswick, NJ, USA.
8
Coalition of Epidemic Preparedness Innovations, London, UK.
9
Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China.
10
Institute of Medical Science, University of Tokyo, Tokyo, Japan.
11
Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia.
12
Medical Sciences Divison, University of Oxford, Oxford, UK.
13
Norwegian Foreign Ministry, Oslo, Norway.
14
Serum Institute of India, Pune, India.
15
Instituto Todos Pela Saúde, São Paulo, Brazil.
16
Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi, India.
17
Sanofi Vaccines, Gentilly, France.
PMID:
37683681
DOI:
10.1016/S0140-6736(23)01775-0
No abstract available